Clinical Trial » Condition » Parkinson's Disease

Parkinson's Disease

Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-Induced Dyskinesias in Advanced Parkinson's Disease
31 May 2009
The study is designed to measure the efficacy and safety of levetiracetam on levodopa-induced dyskinesias in late-stage Parkinson's disease. The patients are planned to be treated with levetiracetam ... 
The Therapeutics Effects of Yoga in Individuals With Parkinson's Disease
31 May 2009
To determine if yoga is beneficial in improving physical function quality of life and medical status in people with Parkinson's disease ... 
Sarizotan in Parkinson Patients With L-Dopa-Induced Dyskinesia
31 May 2009
The primary purpose of the study is to investigate the anti-dyskinetic effect of several doses of sarizotan in Parkinson patients in order to generate information on the dose-response relationship ... 
Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease
31 May 2009
We propose to build on preliminary data evaluating non-dopaminergic/non-motor clinical biomarkers to more fully assess these markers at the threshold of Parkinson disease (PD). ... 
Laser Light Cues for Gait Freezing in Parkinson's Disease
31 May 2009
The purpose of this study is to gather data to see if the Laser Cane and/or U-Step Walker with laser accessory is more effective in aiding with gait freezing than a regular cane/U-Step ... 
Sensory Cues for Freezing in Parkinson's Disease
31 May 2009
The purpose of this study is (1) to determine if patient triggered sensory(auditory, visual and tactile) cues can help treat freezing of gait in Parkinson's disease, and (2) to assess if unexpected ... 
A Trial of MitoQ for the Treatment of People With Parkinson's Disease
31 May 2009
In Parkinson's Disease, the mitochondrial membranes in cells that produce dopamine become damaged by oxidants, leading to the death of these cells and progressive tremor, slowness of ... 
Efficiency of Physiotherapeutic Care in Parkinson's Disease
31 May 2009
In the course of their disease, most patients with Parkinson's Disease (PD) face mounting mobility deficits, including difficulties with walking, balance, posture and transfers. This frequently leads ... 
A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's
31 May 2009
This study was designed to compare the effectiveness and tolerability of a new prolonged release formulation of ropinirole with the currently marketed immediate release formulation which ... 
Farming and Movement Evaluation (FAME) Study
31 May 2009
This study is a collaboration of investigators at the Parkinson's Institute in Sunnyvale, CA, with intramural investigators at NIEHS and NCI. The Principal Investigator is Dr. Caroline Tanner, ... 
Syndicate content